Showing results (311-320 of 431) with videos related to

Sort By:
Pageof 44
Vaccine|October 20, 2020
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platformAriane Volkmann, Anna-Lise Williamson, Heinz Weidenthaler, et al.
BMJ Open|June 17, 2021
Global and regional overview of the inclusion of paediatric surgery in the national health plans of 124 countries: an ecological studyKelsey Landrum, Cesia F Cotache-Condor, Yingling Liu, et al.
Vaccine|August 28, 2024
A Brighton Collaboration standardized template with key considerations for a benefit-risk assessment for the Comirnaty COVID-19 mRNA vaccineShanti Pather, Nicola Charpentier, Frank van den Ouweland, et al.
Gates Open Research|October 23, 2023
Comparison of Masimo Total Hemoglobin SpHb® continuous non-invasive hemoglobin monitoring device with laboratory complete blood count measurement using venous sample: Protocol for an observational substudy of the Pregnancy Risk and Infant Surveillance and Measurement Alliance Maternal and Newborn Health (PRISMA MNH) studyFouzia Farooq, Emily R Smith, Qing Pan, et al.
The Lancet. Global Health|December 18, 2018
Effect of population-based antenatal screening and treatment of genitourinary tract infections on birth outcomes in Sylhet, Bangladesh (MIST): a cluster-randomised clinical trialAnne Cc Lee, Luke C Mullany, Mohammad Quaiyum, et al.
The American Journal of Clinical Nutrition|February 4, 2015
First-trimester plasma tocopherols are associated with risk of miscarriage in rural BangladeshAbu Ahmed Shamim, Kerry Schulze, Rebecca D Merrill, et al.
The Lancet. Global Health|October 14, 2017
Modifiers of the effect of maternal multiple micronutrient supplementation on stillbirth, birth outcomes, and infant mortality: a meta-analysis of individual patient data from 17 randomised trials in low-income and middle-income countriesEmily R Smith, Anuraj H Shankar, Lee S-F Wu, et al.
Vaccine|August 10, 2021
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra virusesJohn H Eldridge, Michael A Egan, Demetrius Matassov, et al.
Science Advances|October 22, 2021
Limited data exist to inform our basic understanding of micronutrient requirements in pregnancyEmily R Smith, Siran He, Kevin C Klatt, et al.
Vaccine|September 10, 2020
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccinesRichard C Condit, Denny Kim, James S Robertson, et al.
Pageof 44